Bioartha Labs Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
- Paid Up Capital ₹ 0.10 M
- Company Age 3 Year, 2 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.60 Cr
- Revenue Growth %
- Profit Growth 116525.86%
- Ebitda 160993.38%
- Net Worth 41517.03%
- Total Assets 49376.00%
About Bioartha Labs
Bioartha Labs Private Limited (BLPL) is a registered startup operating as a Private Limited Indian Non-Government Company incorporated in India on 03 December 2021 (Three years and two months 5 days old ). Its registered office is in Bangaluru, Karnataka, India.
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹1.60 Cr.
Vanamala and Lakshmi serve as directors at the Company.
Company Details
-
Location
Bangaluru, Karnataka, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24299KA2021PTC155169
-
Company No.
155169
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
03 Dec 2021
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Bangalore
Industry
Who are the key members and board of directors at Bioartha Labs?
Board Members (2)
Financial Performance of Bioartha Labs.
Bioartha Labs Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 116525.86% increase in profit. The company's net worth Soared by an impressive increase of 41517.03%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Bioartha Labs?
Unlock access to Bioartha Labs's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Octosense Private LimitedLakshmi is a mutual person
Charges (Loans)
₹16.00 M
₹0
Charges Breakdown by Lending Institutions
- Axis Bank Limited : 1.60 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 11 Jun 2024 | Axis Bank Limited | ₹1.60 Cr | Open |
How Many Employees Work at Bioartha Labs?
Bioartha Labs has a workforce of 0 employees as of Apr 03, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Bioartha Labs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Bioartha Labs's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.